Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

September 03, 2015 11:31 AM ET


Company Overview of CytomX Therapeutics, Inc.

Executive Profile

Sean A. McCarthy D.Phil.

Chief Executive Officer, President and Director, CytomX Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 8 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. Sean A. McCarthy, D.Phil., has been the Chief Executive Officer and President of CytomX Therapeutics, InC. since August 2011. Dr. McCarthy serves as a Board Observer of Optherion Inc. He served as the Board Observer of LEAD Therapeutics, Inc. and TYRX, Inc. He joined the CytomX Therapeutics, LLC on January 5, 2011 as served as its Chief Business Officer since then. Dr. McCarthy served as a Board Observer at Afferent Pharmaceuticals, Inc. since 2008. He served as ...

Corporate Headquarters

343 Oyster Point Boulevard
South San Francisco, California 94080-1913

United States

Phone: 650-515-3185
Fax: 650-351-0353

Board Members Memberships

Chief Executive Officer, President and Director


King's College London
Unknown/Other Education
University of Oxford
St John's College, Oxford University

Other Affiliations

Annual Compensation

Total Annual Compensation$357,075

Stocks Options

All Other Compensation$953
Exercisable Options$27,209,139
Unexercisable Options$8,507,637
Total Number of Options$38,764,561

Total Compensation

Total Annual Cash Compensation$443,726
Total Short Term Compensation$357,075
Other Long Term Compensation$953
Total Calculated Compensation$443,726

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CytomX Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at